Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    November 2025
  1. YAO YH, Li SN, Yin Q, Liu L, et al
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Nov 3. doi: 10.1111/jgh.70140.
    PubMed    


    October 2025
  2. DU Y, Fan H
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1111/jgh.70113.
    PubMed    


  3. KARKRA R
    The Association Between Night Shifts and Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70101.
    PubMed    


    September 2025
  4. AHMED A, Chauhan A, Kumari A, Hokari R, et al
    Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
    J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
    PubMed     Abstract available


    July 2025
  5. YAN Y, Liu L, Shen XJ
    Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
    J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
    PubMed    


  6. YAO Y, You X, Yang S, Xie Y, et al
    Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
    J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
    PubMed     Abstract available


    March 2025
  7. CHENG L, Wang Q, Wu B, Yan X, et al
    Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
    PubMed     Abstract available


    January 2025
  8. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
    Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
    PubMed     Abstract available


  9. YU QX, Wang DD, Dong PJ, Zheng LH, et al
    Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
    PubMed     Abstract available


    December 2024
  10. HISAKI Y, Sawada A, Kobayashi Y, Nishida Y, et al
    Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals.
    J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1111/jgh.16838.
    PubMed     Abstract available


    November 2024
  11. AGGARWAL N, Bhatia U, Dwarakanathan V, Singh AD, et al
    Prevalence and etiologies of non-responsive celiac disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16808.
    PubMed     Abstract available


    August 2024
  12. GONG Q, Xiong F, Zheng Y, Guo Y, et al
    Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16714.
    PubMed     Abstract available


    July 2024
  13. WANG J, Sui WN, Zhao YQ, Meng SY, et al
    Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits.
    J Gastroenterol Hepatol. 2024 Jul 9. doi: 10.1111/jgh.16678.
    PubMed     Abstract available


    May 2024
  14. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    PubMed     Abstract available


    January 2024
  15. CHUAH KH, Mahadeva S
    Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
    J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
    PubMed    


    November 2023
  16. GHOSHAL UC, Mustafa U, Mukhopadhyay SK
    FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16424.
    PubMed     Abstract available


  17. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    PubMed     Abstract available


    September 2023
  18. ZLOOF Y, Peretz L, Braun M, Simchoni M, et al
    Hypermobility spectrum disorders and irritable bowel syndrome: A nationwide study of 1.6 million adolescents.
    J Gastroenterol Hepatol. 2023 Sep 2. doi: 10.1111/jgh.16341.
    PubMed     Abstract available


    June 2023
  19. FUTAGAMI S, Kessoku T, Kasai Y, Higurashi T, et al
    Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1111/jgh.16250.
    PubMed     Abstract available


    March 2023
  20. OKUYAMA Y, Matsui D, Ozaki E, Watanabe Y, et al
    Association of low occlusal force as an oral hypofunction with the prevalence of irritable bowel syndrome in Japanese adults.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16175.
    PubMed     Abstract available


  21. KHOO XH, Chong CW, Talha AM, Philip K, et al
    The impact of diet and ethnicity on Gut Microbiota Variation in Irritable Bowel Syndrome: A Multi-centre Study.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16174.
    PubMed     Abstract available


  22. YASUDA R, Arai K, Kudo T, Nambu R, et al
    Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan.
    J Gastroenterol Hepatol. 2023 Mar 6. doi: 10.1111/jgh.16166.
    PubMed     Abstract available


  23. DENG X, Xiao L, Luo M, Xie P, et al
    Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16159.
    PubMed     Abstract available


    December 2022
  24. YANPING W, Gao X, Cheng Y, Liu M, et al
    The Interaction between Obesity and Visceral Hypersensitivity.
    J Gastroenterol Hepatol. 2022 Dec 7. doi: 10.1111/jgh.16083.
    PubMed     Abstract available


    November 2022
  25. GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
    Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
    J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
    PubMed     Abstract available


    August 2022
  26. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    PubMed     Abstract available


    June 2022
  27. ZHANG Y, Fu F, Zhang L, Zhang W, et al
    Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
    J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
    PubMed     Abstract available


    May 2022
  28. BEK S, Teo YN, Tan XH, Fan KH, et al
    Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
    J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
    PubMed     Abstract available


  29. ABUELAZM M, Abdelazeem B
    Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
    PubMed    


  30. UNO Y
    Paradigm shift in FODMAP theory.
    J Gastroenterol Hepatol. 2022;37:954.
    PubMed    


    April 2022
  31. CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
    Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
    PubMed     Abstract available


  32. FAN K, Eslick GD, Nair PM, Burns GL, et al
    HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
    PubMed     Abstract available


    March 2022
  33. ROTH B, Larsson E, Ohlsson B
    Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
    J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.